Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study

ClinicalTrials.gov ID: NCT07197788

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07197788. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:54 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Endogenex Access Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is designed to collect real-world data on the safety and performance of the Endogenex System in the cohort of participants who were originally randomized to the sham control arm of the ReCET Study.

Study identification

NCT ID: NCT07197788
Recruitment status: Enrolling by invitation
Study type: Interventional
Phase: Not applicable
Lead sponsor: Endogenex, Inc.; Industry
Enrollment: 50 participants

Conditions and interventions

Conditions

Interventions

Endogenex System Device

Device

Eligibility (public fields only)

Age range: 22 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 2026 (Estimated)
Primary completion: Oct 2027 (Estimated)
Completion: Nov 2027 (Estimated)
Last update posted: Oct 19, 2026

2026 – 2027

United States locations

U.S. sites: 8
U.S. states: 5
U.S. cities: 7

Facility	City	State	ZIP	Site status
HCA Florida Mercy Hospital	Miami	Florida	33133	—
Orlando Health	Orlando	Florida	32806	—
Care Access	Quincy	Massachusetts	02169	—
Robert Wood Johnson Medical School	New Brunswick	New Jersey	08901	—
Care Access	Raleigh	North Carolina	27607	—
University of Texas at Austin	Austin	Texas	78712	—
Houston Methodist	Houston	Texas	77030	—
Care Access	Houston	Texas	77054	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07197788, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 19, 2026 · Synced Nov 15, 2026